BioLife Solutions Inc (BLFS)

Net profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -66,427 -102,234 -83,419 -146,098 -139,805 -106,361 -95,965 -15,211 -8,908 4,025 2,813 -21,443 1,983 7,778 19,180 39,812 -1,657 16,293 -18,441 -49,039
Revenue (ttm) US$ in thousands 142,796 154,008 161,427 162,452 161,032 154,468 147,521 138,192 118,837 96,581 74,057 52,773 48,087 41,249 36,673 33,590 27,367 25,090 23,762 22,134
Net profit margin -46.52% -66.38% -51.68% -89.93% -86.82% -68.86% -65.05% -11.01% -7.50% 4.17% 3.80% -40.63% 4.12% 18.86% 52.30% 118.52% -6.05% 64.94% -77.61% -221.56%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-66,427K ÷ $142,796K
= -46.52%

The net profit margin of BioLife Solutions Inc has varied significantly over the past few quarters. It reached its lowest point of -89.93% in March 2023, indicating that for every dollar of revenue generated, the company incurred a net loss of approximately $0.90.

The margin improved slightly in the subsequent quarters but remained negative until June 2022. From March 2022 to December 2022, there was a notable improvement in profitability, with the net profit margin turning positive and reaching as high as 118.52% in March 2020. During this period, the company was able to generate substantial profits relative to its revenue.

However, the profitability declined sharply in the following quarters, with the net profit margin falling to -221.56% in March 2019. This indicates that the company was incurring losses greater than its revenue.

Overall, the fluctuating net profit margins reflect the company's inconsistent financial performance and highlight the challenges BioLife Solutions Inc has faced in maintaining profitability over the analyzed period.


Peer comparison

Dec 31, 2023